Stay updated on Seladelpar in PBC Subjects Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.

Latest updates to the Seladelpar in PBC Subjects Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA banner announces NIH website updates and a terminology transition. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference1%

- Check21 days agoChange DetectedThe 403 error page’s footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now loads a 403 Forbidden error page, blocking access to the study record. The visible content is replaced by a site-wide error message and footer, indicating an access restriction rather than a study data update.SummaryDifference18%

- Check42 days agoChange DetectedThe page revision label updated from v3.6.6 to v3.7.0, indicating a new build of the site’s page template. This change does not modify the study details or presented information.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the page metadata rather than substantive content changes.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now documents Revision: v3.6.5, replacing the previous v3.6.4, indicating a minor platform update.SummaryDifference0.0%

Stay in the know with updates to Seladelpar in PBC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.